Anthony Letai was Named as the New Director of NIH's National Cancer Institute

Anthony Letai

Rare Cancer Day 2025: Illuminating the Hidden Frontiers of Oncology

Rare Cancer Day 2025

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Hesham ElGhazaly: Egypt’s Voice and Commitment to Global Collaboration

Hesham ElGhazaly

Visa Restrictions Threaten U.S. Health Care Workforce

Visa Restrictions

Julie Gralow: Let’s Push for Dose Optimization for All Cancer Treatments

Julie Gralow

Carlos Rodriguez-Galindo: GICC Progress Spotlighted at UNGA 80

Carlos Rodriguez-Galindo

Triple Combination of Encorafenib, Cetuximab, and Nivolumab in MSS BRAFV600E Metastatic Colorectal Cancer

nivolumab encorafenib cetuximab for brafv600e MSS CRC

OncoCalendar

« All Events

  • This event has passed.

Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC

Dec 30, 2024 • 10:00 AM - 12:00 PM
Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC

Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC will be held at December 30, 2024.

This Exclusive Virtual Course focuses on the latest updates in lung cancer treatment in Eastern Europe and the Balkan States, with a particular emphasis on immunotherapy. In Series I, leading thoracic oncology experts from the region will discuss how immunotherapy is revolutionizing lung cancer care. Key topics include the integration of biomarkers for immunotherapy, effective management strategies for advanced disease, and addressing challenges such as pneumonitis. Participants will gain valuable insights into the evolving landscape of lung cancer treatment, particularly in Eastern Europe and the Balkans, and learn how immunotherapy is improving patient outcomes in these regions.

See the Speakers of the Course Below:

Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC

Details

Date:
Dec 30, 2024
Time:
10:00 AM - 12:00 PM
Website:
https://www.iaslc.org/node/35049

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org